{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:32:36Z","timestamp":1782235956482,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,5]]},"DOI":"10.7759\/cureus.87346","type":"journal-article","created":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T18:54:47Z","timestamp":1751741687000},"source":"Crossref","is-referenced-by-count":2,"title":["Sporadic Lymphangioleiomyomatosis in a 35-Year-Old Female Patient: A Rare Cause of Spontaneous Pneumothorax"],"prefix":"10.7759","author":[{"given":"Peter N","family":"Rodenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Elefteratos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L","family":"Rodenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colton","family":"Herrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032492","article-title":"Clinical features and outcomes of male patients with lymphangioleiomyomatosis: a review","volume":"101","author":"Zhang H","year":"2022","unstructured":"Zhang H, Hu Z, Wang S, Wu K, Yang Q, Song X. Clinical features and outcomes of male patients with lymphangioleiomyomatosis: a review. Medicine (Baltimore). 2022, 101:e32492. 10.1097\/MD.0000000000032492","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcr116","article-title":"Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis","volume":"104","author":"Harknett EC","year":"2011","unstructured":"Harknett EC, Chang WY, Byrnes S, et al.. Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM. 2011, 104:971-9. 10.1093\/qjmed\/hcr116","journal-title":"QJM"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-012-9419-3","article-title":"Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry","volume":"191","author":"Oprescu N","year":"2013","unstructured":"Oprescu N, McCormack FX, Byrnes S, Kinder BW. Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry. Lung. 2013, 191:35-42. 10.1007\/s00408-012-9419-3","journal-title":"Lung"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American Thoracic Society\/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack FX","year":"2016","unstructured":"McCormack FX, Gupta N, Finlay GR, et al.. Official American Thoracic Society\/Japanese Respiratory Society clinical practice guidelines: lymphangioleiomyomatosis diagnosis and management. Am J Respir Crit Care Med. 2016, 194:748-61. 10.1164\/rccm.201607-1384ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S50780","article-title":"Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis","volume":"7","author":"Taveira-DaSilva AM","year":"2015","unstructured":"Taveira-DaSilva AM, Moss J. Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis. Clin Epidemiol. 2015, 7:249-57. 10.2147\/CLEP.S50780","journal-title":"Clin Epidemiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1517\/21678707.2016.1148597","article-title":"Epidemiology, pathogenesis and diagnosis of lymphangioleiomyomatosis","volume":"4","author":"Taveira-DaSilva AM","year":"2016","unstructured":"Taveira-DaSilva AM, Moss J. Epidemiology, pathogenesis and diagnosis of lymphangioleiomyomatosis. Expert Opin Orphan Drugs. 2016, 4:369-78. 10.1517\/21678707.2016.1148597","journal-title":"Expert Opin Orphan Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.11.6085","article-title":"Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis","volume":"97","author":"Carsillo T","year":"2000","unstructured":"Carsillo T, Astrinidis A, Henske EP. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci U S A. 2000, 97:6085-90. 10.1073\/pnas.97.11.6085","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref8","article-title":"Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis","volume":"35","author":"Grzegorek I","year":"2015","unstructured":"Grzegorek I, Lenze D, Chabowski M, et al.. Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis. Anticancer Res. 2015, 35:3353-60.","journal-title":"Anticancer Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0898","article-title":"Lymphangioleiomyomatosis: a clinical update","volume":"133","author":"McCormack FX","year":"2008","unstructured":"McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest. 2008, 133:507-16. 10.1378\/chest.07-0898","journal-title":"Chest"},{"key":"ref10","article-title":"Lymphangioleiomyomatosis: diagnosis, clinical features, and management","volume":"13","author":"Taveira-DaSilva AM","year":"2018","unstructured":"Taveira-DaSilva AM, Hathaway O, Stylianou M, Moss J, Henske EP. Lymphangioleiomyomatosis: diagnosis, clinical features, and management. Orphanet J Rare Dis. 2018, 13:1-10.","journal-title":"Orphanet J Rare Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00228-9","article-title":"Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management","volume":"9","author":"McCarthy C","year":"2021","unstructured":"McCarthy C, Gupta N, Johnson SR, Yu JJ, McCormack FX. Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management. Lancet. 2021, 9:1313-27. 10.1016\/S2213-2600(21)00228-9","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201411-2094CI","article-title":"Diffuse cystic lung disease. Part I","volume":"191","author":"Gupta N","year":"2015","unstructured":"Gupta N, Vassallo R, Wikenheiser-Brokamp KA, McCormack FX. Diffuse cystic lung disease. Part I. Am J Respir Crit Care Med. 2015, 191:1354-66. 10.1164\/rccm.201411-2094CI","journal-title":"Am J Respir Crit Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00076209","article-title":"European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis","volume":"35","author":"Johnson SR","year":"2010","unstructured":"Johnson SR, Cordier JF, Lazor R, et al.. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J. 2010, 35:14-26. 10.1183\/09031936.00076209","journal-title":"Eur Respir J"},{"key":"ref14","article-title":"Alpha-1 Antitrypsin Deficiency","author":"Meseeha M","year":"2024","unstructured":"Meseeha M, Sankari A, Attia M. Alpha-1 Antitrypsin Deficiency. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/2249-4863.130336","article-title":"Recurrent pneumothorax in a young female with pulmonary lymphangiomyomatosis: a case report and overview of literature","volume":"3","author":"Jain VV","year":"2014","unstructured":"Jain VV, Gupta OP, Jajoo S, Khiangate B. Recurrent pneumothorax in a young female with pulmonary lymphangiomyomatosis: a case report and overview of literature. J Family Med Prim Care. 2014, 3:86-8. 10.4103\/2249-4863.130336","journal-title":"J Family Med Prim Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack FX","year":"2011","unstructured":"McCormack FX, Inoue Y, Moss J, et al.. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011, 364:1595-606. 10.1056\/NEJMoa1100391","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/382983-sporadic-lymphangioleiomyomatosis-in-a-35-year-old-female-patient-a-rare-cause-of-spontaneous-pneumothorax","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T18:54:47Z","timestamp":1751741687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/382983-sporadic-lymphangioleiomyomatosis-in-a-35-year-old-female-patient-a-rare-cause-of-spontaneous-pneumothorax"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,5]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.87346","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,5]]}}}